VANCOMYCIN HYDROCHLORIDE for I. V. Infusion 0.5g "MEEK"（バンコマイシン塩酸塩点滴静注用0.5g「MEEK」）
|
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
|
|
Brand name :
|
VANCOMYCIN HYDROCHLORIDE for I. V. Infusion 0.5g "MEEK"
|
|
 |
Effects of this medicine
This medicine is a glycopeptide antibiotic which inhibits synthesis of the bacterial cell wall to exert an antibacterial effect.
It is usually used to treat a wide range of infections such as sepsis, infections in surgical/orthopedic cases, respiratory infection, intra-abdominal infection and intracerebral infection, and febrile neutropenia suspected to be due to methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-resistant coagulase-negative Staphylococcus (MRCNS) infection.
|
Before using this medicine, be sure to tell your doctor and pharmacist
-
If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
If you have previously experienced shock.
If you have hearing loss.
-
If you are pregnant or breastfeeding.
-
If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
|
Dosing schedule (How to take this medicine)
-
Your dosing schedule prescribed by your doctor is (( to be written by a healthcare professional))
-
In general, this medicine is administered by intravenous infusion over 60 minutes or longer every 6 hours or every 12 hours in adults, every 12 hours or every 24 hours in the elderly, in 2 to 4 divided doses a day in children and infants, every 12 hours in newborns up to 1 week of age or every 8 hours in newborns up to 1 month of age.
-
The treatment period with this medicine is determined based on your symptoms.
-
You should keep at rest from the beginning to the end of drip infusion.
|
Precautions while taking this medicine
|
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include rash, itching, redness, hives, facial flush, blister, anemia, fever, phlebitis, vascular pain, skin vasculitis and injection site pain. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
-
respiratory distress, generalized flushing, edema [shock, anaphylaxis]
-
edema, decreased urine output or anuria, fever [acute renal failure, interstitial nephritis]
-
palpitation/shortness of breath, sore throat, gum bleeding [pancytopenia, agranulocytosis, thrombocytopenia]
-
fever, redness/swelling of skin and mucosa with rash and blister, hyperemia of the bulbar conjunctiva [toxic epidermal necrolysis, muco-cutaneo-ocular syndrome, exfoliative dermatitis]
-
rash, fever, swollen lymph nodes [drug-induced hypersensitivity syndrome]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.
|
|
